Li, Zhongchao http://orcid.org/0000-0001-7529-2587
Liu, Jing
Zhang, Bo http://orcid.org/0000-0002-5578-5488
Yue, Jinbo
Shi, Xuetao http://orcid.org/0000-0003-4313-6664
Cui, Kai http://orcid.org/0000-0002-3672-0160
Liu, Zhaogang
Chang, Zhibin
Sun, Zhicheng http://orcid.org/0009-0009-0504-4807
Li, Mingming http://orcid.org/0000-0003-2136-4850
Yang, Yue http://orcid.org/0000-0001-7249-8571
Ma, Zhao
Li, Lei http://orcid.org/0009-0008-9053-9785
Zhang, Chengsheng
Sun, Pengfei http://orcid.org/0000-0002-0265-6498
Zhong, Jingtao http://orcid.org/0000-0003-3686-9720
Zhao, Lei http://orcid.org/0000-0002-9919-5981
Article History
Received: 29 December 2023
Accepted: 29 March 2024
First Online: 16 April 2024
Competing interests
: L.Z. is on the speakers’ bureau for Bayer, MSD, AstraZeneca, Roche, BeiGene, Innovent, Junshi Biosciences, and Hengrui Medicine. The remaining authors declare no competing interests.